Literature DB >> 35066646

Inactivating NHLH2 variants cause idiopathic hypogonadotropic hypogonadism and obesity in humans.

A Kemal Topaloglu1,2, Enver Simsek3, Matthew A Kocher4, Jamala Mammadova5, Ece Bober6, Leman Damla Kotan7, Ihsan Turan7, Can Celiloglu7, Fatih Gurbuz7, Bilgin Yuksel7, Deborah J Good4,8.   

Abstract

Metabolism has a role in determining the time of pubertal development and fertility. Nonetheless, molecular/cellular pathways linking metabolism/body weight to puberty/reproduction are unknown. The KNDy (Kisspeptin/Neurokinin B/Dynorphin) neurons in the arcuate nucleus of the hypothalamus constitute the GnRH (gonadotropin-releasing hormone) pulse generator. We previously created a mouse model with a whole-body targeted deletion of nescient helix-loop-helix 2 (Nhlh2; N2KO), a class II member of the basic helix-loop-helix family of transcription factors. As this mouse model features pubertal failure and late-onset obesity, we wanted to study whether NHLH2 represents a candidate molecule to link metabolism and puberty in the hypothalamus. Exome sequencing of a large Idiopathic Hypogonadotropic Hypogonadism cohort revealed obese patients with rare sequence variants in NHLH2, which were characterized by in-silico protein analysis, chromatin immunoprecipitation, and luciferase reporter assays. In vitro heterologous expression studies demonstrated that the variant p.R79C impairs Nhlh2 binding to the Mc4r promoter. Furthermore, p.R79C and other variants show impaired transactivation of the human KISS1 promoter. These are the first inactivating human variants that support NHLH2's critical role in human puberty and body weight control. Failure to carry out this function results in the absence of pubertal development and late-onset obesity in humans.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35066646     DOI: 10.1007/s00439-021-02422-9

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   5.881


  42 in total

Review 1.  The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism.

Authors:  Suzy D C Bianco; Ursula B Kaiser
Journal:  Nat Rev Endocrinol       Date:  2009-08-25       Impact factor: 43.330

2.  Kabuki syndrome: international consensus diagnostic criteria.

Authors:  Margaret P Adam; Siddharth Banka; Hans T Bjornsson; Olaf Bodamer; Albert E Chudley; Jaqueline Harris; Hiroshi Kawame; Brendan C Lanpher; Andrew W Lindsley; Giuseppe Merla; Noriko Miyake; Nobuhiko Okamoto; Constanze T Stumpel; Norio Niikawa
Journal:  J Med Genet       Date:  2018-12-04       Impact factor: 6.318

3.  Autozygosity mapping with exome sequence data.

Authors:  Ian M Carr; Sanjeev Bhaskar; James O'Sullivan; Mohammed A Aldahmesh; Hanan E Shamseldin; Alexander F Markham; David T Bonthron; Graeme Black; Fowzan S Alkuraya
Journal:  Hum Mutat       Date:  2012-10-22       Impact factor: 4.878

4.  Two single nucleotide polymorphisms in the human nescient helix-loop-helix 2 (NHLH2) gene reduce mRNA stability and DNA binding.

Authors:  Numan Al Rayyan; Umesh D Wankhade; Korie Bush; Deborah J Good
Journal:  Gene       Date:  2012-09-28       Impact factor: 3.688

5.  Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin.

Authors:  F F Chehab; M E Lim; R Lu
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

6.  Changes in hypothalamic KiSS-1 system and restoration of pubertal activation of the reproductive axis by kisspeptin in undernutrition.

Authors:  J M Castellano; V M Navarro; R Fernández-Fernández; R Nogueiras; S Tovar; J Roa; M J Vazquez; E Vigo; F F Casanueva; E Aguilar; L Pinilla; C Dieguez; M Tena-Sempere
Journal:  Endocrinology       Date:  2005-06-02       Impact factor: 4.736

7.  Leptin signaling regulates hypothalamic expression of nescient helix-loop-helix 2 (Nhlh2) through signal transducer and activator 3 (Stat3).

Authors:  Numan Al Rayyan; Jinhua Zhang; Amy S Burnside; Deborah J Good
Journal:  Mol Cell Endocrinol       Date:  2014-01-29       Impact factor: 4.102

8.  Medical sequencing at the extremes of human body mass.

Authors:  Nadav Ahituv; Nihan Kavaslar; Wendy Schackwitz; Anna Ustaszewska; Joel Martin; Sybil Hebert; Heather Doelle; Baran Ersoy; Gregory Kryukov; Steffen Schmidt; Nir Yosef; Eytan Ruppin; Roded Sharan; Christian Vaisse; Shamil Sunyaev; Robert Dent; Jonathan Cohen; Ruth McPherson; Len A Pennacchio
Journal:  Am J Hum Genet       Date:  2007-03-05       Impact factor: 11.025

9.  Arcuate Nucleus Overexpression of NHLH2 Reduces Body Mass and Attenuates Obesity-Associated Anxiety/Depression-like Behavior.

Authors:  Rodrigo S Carraro; Guilherme A Nogueira; Davi Sidarta-Oliveira; Rodrigo S Gaspar; Nathalia R Dragano; Joseane Morari; Vanessa C D Bobbo; Eliana P Araujo; Natalia F Mendes; Ariane M Zanesco; Natalia Tobar; Celso D Ramos; Jéssica M Toscaro; Marcio C Bajgelman; Licio A Velloso
Journal:  J Neurosci       Date:  2021-10-21       Impact factor: 6.709

10.  Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.

Authors:  Lisa C Burnett; Charles A LeDuc; Carlos R Sulsona; Daniel Paull; Richard Rausch; Sanaa Eddiry; Jayne F Martin Carli; Michael V Morabito; Alicja A Skowronski; Gabriela Hubner; Matthew Zimmer; Liheng Wang; Robert Day; Brynn Levy; Ilene Fennoy; Beatrice Dubern; Christine Poitou; Karine Clement; Merlin G Butler; Michael Rosenbaum; Jean Pierre Salles; Maithe Tauber; Daniel J Driscoll; Dieter Egli; Rudolph L Leibel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.